Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-020053
Filing Date
2014-11-07
Accepted
2014-11-07 16:04:02
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bota20140930_10q.htm 10-Q 776233
2 EXHIBIT 31.1 ex31-1.htm EX-31 16312
3 EXHIBIT 31.2 ex31-2.htm EX-31 16739
4 EXHIBIT 32.1 ex32-1.htm EX-32 8490
  Complete submission text file 0001437749-14-020053.txt   5145660

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS bota-20140930.xml EX-101.INS 896174
6 EXHIBIT 101.SCH bota-20140930.xsd EX-101.SCH 36781
7 EXHIBIT 101.CAL bota-20140930_cal.xml EX-101.CAL 25828
8 EXHIBIT 101.DEF bota-20140930_def.xml EX-101.DEF 168886
9 EXHIBIT 101.LAB bota-20140930_lab.xml EX-101.LAB 240217
10 EXHIBIT 101.PRE bota-20140930_pre.xml EX-101.PRE 174082
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 141204911
SIC: 2836 Biological Products, (No Diagnostic Substances)